logo

Immunogen Inc (IMGN)



Trade IMGN now with
  Date
  Headline
11/3/2017 6:41:30 AM ImmunoGen Q3 Net Loss $56.7 Mln Or $0.61/Shr Vs Loss Of $44.7 Mln Or $0.51/Shr Last Year
11/3/2017 4:45:45 AM In The Spotlight: ImmunoGen
10/16/2017 8:09:46 AM ImmunoGen Announces IND Application For IMGN632 For Hematological Malignancies Is Active
10/11/2017 4:16:54 PM ImmunoGen Announces Closing Of Public Offering Of Common Stock
10/4/2017 4:02:00 PM ImmunoGen Announces Proposed Public Offering Of Common Stock
8/29/2017 6:34:46 AM Jazz Pharma, ImmunoGen Announce Strategic Collaboration And Option Agreement To Commercialize ADC Products
7/28/2017 6:35:13 AM ImmunoGen Q2 Net Loss $8.9 Mln Or $0.10 Per Share
7/6/2017 6:28:16 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) 2019 Estimate To -1.78 From -1.69
7/6/2017 6:27:56 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) 2018 Estimate To -1.81 From -1.63
7/6/2017 6:27:17 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) 2017 Estimate To -0.80 From -1.37
7/6/2017 6:26:55 AM RBC Capital Markets Is Increasing Immunogen Inc (IMGN) Q4 18 Estimate To -0.42 From -0.45
7/6/2017 6:26:37 AM RBC Capital Markets Is Cutting Immunogen Inc (IMGN) Q3 18 Estimate To -0.48 From -0.42
7/6/2017 6:26:20 AM RBC Capital Markets Is Lowering Immunogen Inc (IMGN) Q2 18 Estimate To -0.45 From -0.43